Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Alopecia areata is a genetic and immune-related hair loss condition that is often associated with other autoimmune diseases and does not typically cause permanent damage to hair follicles.

Transplanted hair follicles can resist hair loss from an autoimmune condition better than natural hair.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

The dog with an Alopecia Areata-like condition showed signs of an autoimmune disease and partially regrew hair without treatment, suggesting dogs could be models for human AA research.

The document concludes that immune system abnormalities cause alopecia areata, but the exact process is still not completely understood.

Alopecia areata causes sudden hair loss, often resolves within a year, but can recur.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Beta-blockers can cause rare skin side-effects, which usually improve after stopping the medication.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

Simvastatin helps hair regrowth in autoimmune alopecia by directly affecting T cells.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

IL-33 is linked to hair follicle damage in psoriasis and could be a treatment target for hair loss in this condition.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

An imbalance in gut bacteria is linked to skin immune diseases and may affect their outcomes and related health issues.

A cat's skin condition was fully cured with cyclosporine A after other treatments failed.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Rhamnose may help hair growth and pigmentation, making it a potential treatment for hair loss.

Skin changes help detect graft-versus-host reaction early after bone marrow transplants.

Blocking interferon-gamma might help treat various autoimmune diseases.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

The conference concluded that understanding hair and nail disorders is important, iron deficiency may be linked to hair loss, and while some treatments for skin conditions are effective, they may have risks and high costs.

Blocking LFA-1 prevents hair loss in mice.